Brown Miller Wealth Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$290K Hold
1,278
0.07% 172
2026
Q1
$220K Buy
1,278
+84
+7% +$15.6K 0.06% 186
2025
Q4
$238K Buy
+1,194
New +$217K 0.07% 177

Other funds holding CRL

Brown Miller Wealth Management's CRL Position: Q2 2026 in Review

Brown Miller Wealth Management held its Charles River Laboratories (CRL) position steady in Q2 2026 at 1,278 shares worth $290K. The position accounts for 0.07% of the portfolio, ranked #172.

Brown Miller Wealth Management first reported a position in CRL in Q4 2025 and has held it in 3 quarters since. 105 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Brown Miller Wealth Management held 1,278 shares of Charles River Laboratories worth $290K as of Q2 2026.
  • Brown Miller Wealth Management left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up 0.07% of Brown Miller Wealth Management's portfolio in Q2 2026, its #172 holding.
  • Brown Miller Wealth Management first reported a position in Charles River Laboratories in Q4 2025 and has held it in 3 quarters since.
  • 105 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Brown Miller Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.